ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
AbbVie reports 99% cure rate for pan-genotypic Hep C therapy
April 24, 2017AbbVie has released late-stage clinical data showing high cure rates for its experimental ribavirin-free hepatitis C therapy ... -
Allergan and Novartis join forces to develop NASH combo therapy
April 19, 2017Allergan and Novartis have announced a new partnership to conduct a clinical trial in the treatment area of non-alcoholic steatohepatitis (NASH), evaluating two of their treatments as a combination therapy. -
FDA Grants Breakthrough Therapy Designation for Rituxan®in Pemphigus Vulgaris
March 27, 2017Genentech, a member of the Roche Group has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation status to Rituxan® (rituximab) for pemphigus vulgaris... -
Cancer clinic turns to crowdfunding to boost therapy access
March 14, 2017A cancer clinic based in London has taken the unprecedented step of launching a crowdfunding appeal striving to raise ... -
Regenerative medicine market worth US$38.7 billion by 2021
February 23, 2017An overview of the major drivers and challenges impacting the Regenerative medicine market along with market share analysis
Pharma Sources Insight January 2025
